Zuranolone Pharmacokinetics (PK) and Safety Study Adolescent Participants With Major Depressive Disorder (MDD)
Study Summary: This study is exploring how a medicine called Zuranolone works in the body and its safety for teenagers aged 12-17 with Major Depressive Disorder (MDD). MDD is a serious mood condition causing persistent sadness. Pharmacokinetics (PK) is the study of how the body absorbs and processes a drug. To join, participants must meet specific criteria, like having a high depression score and being able to attend all visits with a parent or caregiver. Unfortunately, teens with other serious mental health conditions or a history of substance misuse cannot participate.
- Commitment: Participants will need to attend multiple study visits.
- Safety: The study will check how Zuranolone affects the body.
- Eligibility: Only certain adolescents with MDD can join.
Participants will help researchers understand if Zuranolone is safe and how it works in young people with depression. 🤝
Study details
NCT05655507
Sage Therapeutics
8 July 2024
Not finding the right Trial?
,
You have contacted , on
Your message has been sent to the study team at ,
What happens next?
- You can expect the study team to contact you via email or phone in the next few days.
- Sign up as volunteer to help accelerate the development of new treatments and to get notified about similar trials.
You are contacting
Primary Contact
FAQs
Learn more about clinical trials
What is a clinical trial?
Why should I take part in a clinical trial?
How long does a clinical trial take place?
Do I get compensated for taking part in clinical trials?
How safe are clinical trials?
Study Definition
WikipediaAdd a private note
- Select a piece of text.
- Add notes visible only to you.
- Send it to people through a passcode protected link.